BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15271863)

  • 1. And what about the endothelium? On the predominance of cerebral superoxide formation for angiotensin II-induced systemic hypertension.
    Brandes RP
    Circ Res; 2004 Jul; 95(2):122-4. PubMed ID: 15271863
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.
    Zimmerman MC; Lazartigues E; Sharma RV; Davisson RL
    Circ Res; 2004 Jul; 95(2):210-6. PubMed ID: 15192025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II.
    Widder JD; Guzik TJ; Mueller CF; Clempus RE; Schmidt HH; Dikalov SI; Griendling KK; Jones DP; Harrison DG
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):762-8. PubMed ID: 17272743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
    Schulman IH; Zhou MS; Raij L
    J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice.
    Takaki A; Morikawa K; Murayama Y; Yamagishi H; Hosoya M; Ohashi J; Shimokawa H
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):510-7. PubMed ID: 19034034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oxidative stress and vascular dysfunction in hypertension].
    Yoshizumi M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():43-7. PubMed ID: 15171339
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired vasorelaxation in inbred mice is associated with alterations in both nitric oxide and super oxide pathways.
    Chen C; Korshunov VA; Massett MP; Yan C; Berk BC
    J Vasc Res; 2007; 44(6):504-12. PubMed ID: 17664889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase.
    Sarr M; Chataigneau M; Martins S; Schott C; El Bedoui J; Oak MH; Muller B; Chataigneau T; Schini-Kerth VB
    Cardiovasc Res; 2006 Sep; 71(4):794-802. PubMed ID: 16822492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension.
    Majid DS; Kopkan L
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):946-52. PubMed ID: 17645645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of oxidative stress in angiotensin-II mediated contraction of human conduit arteries in patients with cardiovascular disease.
    Püntmann VO; Hussain MB; Mayr M; Xu Q; Singer DR
    Vascul Pharmacol; 2005 Oct; 43(4):277-82. PubMed ID: 16243586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of extracellular superoxide dismutase contributes to the development of high-volume hypertension.
    Jung O; Marklund SL; Xia N; Busse R; Brandes RP
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):470-7. PubMed ID: 17170376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction.
    Agarwal A; Nandipati KC; Sharma RK; Zippe CD; Raina R
    J Androl; 2006; 27(3):335-47. PubMed ID: 16339449
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased mitochondrial superoxide in the brain, but not periphery, sensitizes mice to angiotensin II-mediated hypertension.
    Case AJ; Tian J; Zimmerman MC
    Redox Biol; 2017 Apr; 11():82-90. PubMed ID: 27889641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II.
    Girouard H; Park L; Anrather J; Zhou P; Iadecola C
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):303-9. PubMed ID: 17138940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superoxide anion mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation.
    Lu C; Su LY; Lee RM; Gao YJ
    Eur J Pharmacol; 2008 Jul; 589(1-3):188-93. PubMed ID: 18538762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
    Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy.
    Schrader LI; Kinzenbaw DA; Johnson AW; Faraci FM; Didion SP
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2576-81. PubMed ID: 17962626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.